Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,419 | 2,961 | 1,565 | 6,417 | 59 |
| Marketable Securities | 2,478 | 5,000 | 10,000 | 10,000 | N/A |
| TOTAL | $4,903 | $8,114 | $11,621 | $16,445 | $67 |
| Non-Current Assets | |||||
| PPE Net | 215 | 142 | 441 | 713 | 82 |
| Other Non-Current Assets | 637 | 183 | 560 | 862 | 191 |
| TOTAL | $853 | $324 | $1,000 | $1,574 | $273 |
| Total Assets | $5,756 | $8,438 | $12,622 | $18,019 | $340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3 | 8 | 11 | 16 | 83 |
| Accrued Expenses | 348 | 125 | 158 | 151 | 573 |
| TOTAL | $664 | $194 | $607 | $578 | $4,338 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 232 | 87 | 217 | 509 | 0 |
| TOTAL | $232 | $26 | $25 | $360 | $N/A |
| Total Liabilities | $895 | $220 | $632 | $938 | $4,338 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 0 | 0 | 0 | 0 |
| Retained earnings | -25,201 | -21,617 | -17,315 | -11,444 | -3,998 |
| Other shareholders' equity | -65 | -46 | -128 | 15 | 0 |
| TOTAL | $4,860 | $8,219 | $11,989 | $17,081 | $-3,998 |
| Total Liabilities And Equity | $5,756 | $8,438 | $12,622 | $18,019 | $340 |